Document is current
Any future updates will be listed below
-
Authors
Ikoma, Yoshikazu https://orcid.org/0009-0008-4780-9137
Nakamura, Nobuhiko https://orcid.org/0000-0003-1682-7777
Kaneda, Yuto
Takamori, Hiroyuki https://orcid.org/0000-0002-0179-3335
Seki, Tomokazu
Hiramoto, Nobuhiro https://orcid.org/0000-0002-0472-6680
Kitagawa, Junichi
Kanda, Junya https://orcid.org/0000-0002-6704-3633
Fujita, Kei
Morishita, Tetsuji
Ochi, Yotaro https://orcid.org/0000-0001-8472-6164
Chiba, Shigeru
Sasaki, Nana
Ichii, Michiko
Imada, Kazunori https://orcid.org/0000-0002-0945-0513
Watanabe, Mizuki https://orcid.org/0000-0002-4030-4653
Hishizawa, Masakatsu
Miyahara, Yasuko
Maesako, Yoshitomo
Tanaka, Yasuhiro
Oka, Satoko
Tsuji, Masaaki
Yoshihara, Satoshi https://orcid.org/0000-0002-8537-2422
Mitani, Kinuko
Ueda, Yasunori
Kitano, Toshiyuki
Watanabe, Mitsumasa https://orcid.org/0000-0003-4889-7999
Sezaki, Nobuo
Kondo, Tadakazu https://orcid.org/0000-0002-8959-6271
Kasahara, Senji
Takaori-Kondo, Akifumi https://orcid.org/0000-0001-7678-4284
Kanemura, Nobuhiro https://orcid.org/0000-0001-8449-9918
Ogawa, Seishi https://orcid.org/0000-0002-7778-5374
Nannya, Yasuhito https://orcid.org/0000-0002-6526-0992
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (23tk0124003h0001, 23ck0106875h0001, 23tk0124003h0001)
International Joint Usage/Research Center, IMSUT
MEXT | Japan Society for the Promotion of Science (24H00009)
- License Information
-
More Information
Article History
Received: 9 December 2024
Revised: 9 April 2025
Accepted: 14 April 2025
First Online: 21 April 2025
Competing interests
: YI received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK. NN received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK. YK received honoraria from AbbVie GK. NH received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK. J. Kanda received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK. YO received research funding and honoraria from Nippon Shinyaku Co., Ltd. SC received honoraria from Nippon Shinyaku Co., Ltd. M.Ichii received honoraria from Nippon Shinyaku Co., Ltd. KI received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK. SY received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK. KM received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK. T. Kitano received honoraria from Nippon Shinyaku Co., Ltd. SK received honoraria from AbbVie GK. AT received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK. NK received honoraria from AbbVie GK. S.Ogawa received research funding from Nippon Shinyaku Co., Ltd. YN received honoraria from Nippon Shinyaku Co., Ltd. and AbbVie GK.
